Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Mar 13;319(10):993-1001.
doi: 10.1001/jama.2018.0949.

Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical Trial

David M P van Meenen  1 , Sophia M van der Hoeven  1 , Jan M Binnekade  1 , Corianne A J M de Borgie  2 , Maruschka P Merkus  2 , Frank H Bosch  3 , Henrik Endeman  4 , Jasper J Haringman  5 , Nardo J M van der Meer  6 , Hazra S Moeniralam  7 , Mathilde Slabbekoorn  8 , Marcella C A Muller  8 , Willemke Stilma  4 , Bart van Silfhout  7 , Ary Serpa Neto  9 , Hans F M Ter Haar  5 , Jan Van Vliet  3 , Jan Willem Wijnhoven  6 , Janneke Horn  1   10 , Nicole P Juffermans  1   10 , Paolo Pelosi  11 , Marcelo Gama de Abreu  12 , Marcus J Schultz  1   10   13 , Frederique Paulus  1
Affiliations
Randomized Controlled Trial

Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical Trial

David M P van Meenen et al. JAMA. .

Abstract

Importance: It remains uncertain whether nebulization of mucolytics with bronchodilators should be applied for clinical indication or preventively in intensive care unit (ICU) patients receiving invasive ventilation.

Objective: To determine if a strategy that uses nebulization for clinical indication (on-demand) is noninferior to one that uses preventive (routine) nebulization.

Design, setting, and participants: Randomized clinical trial enrolling adult patients expected to need invasive ventilation for more than 24 hours at 7 ICUs in the Netherlands.

Interventions: On-demand nebulization of acetylcysteine or salbutamol (based on strict clinical indications, n = 471) or routine nebulization of acetylcysteine with salbutamol (every 6 hours until end of invasive ventilation, n = 473).

Main outcomes and measures: The primary outcome was the number of ventilator-free days at day 28, with a noninferiority margin for a difference between groups of -0.5 days. Secondary outcomes included length of stay, mortality rates, occurrence of pulmonary complications, and adverse events.

Results: Nine hundred twenty-two patients (34% women; median age, 66 (interquartile range [IQR], 54-75 years) were enrolled and completed follow-up. At 28 days, patients in the on-demand group had a median 21 (IQR, 0-26) ventilator-free days, and patients in the routine group had a median 20 (IQR, 0-26) ventilator-free days (1-sided 95% CI, -0.00003 to ∞). There was no significant difference in length of stay or mortality, or in the proportion of patients developing pulmonary complications, between the 2 groups. Adverse events (13.8% vs 29.3%; difference, -15.5% [95% CI, -20.7% to -10.3%]; P < .001) were more frequent with routine nebulization and mainly related to tachyarrhythmia (12.5% vs 25.9%; difference, -13.4% [95% CI, -18.4% to -8.4%]; P < .001) and agitation (0.2% vs 4.3%; difference, -4.1% [95% CI, -5.9% to -2.2%]; P < .001).

Conclusions and relevance: Among ICU patients receiving invasive ventilation who were expected to not be extubated within 24 hours, on-demand compared with routine nebulization of acetylcysteine with salbutamol did not result in an inferior number of ventilator-free days. On-demand nebulization may be a reasonable alternative to routine nebulization.

Trial registration: clinicaltrials.gov Identifier: NCT02159196.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Figures

Figure 1.
Figure 1.. Flow of Patients in the NEBULAE Trial
ICU indicates intensive care unit; NEBULAE, Preventive Nebulization of Mucolytic Agents and Bronchodilating Drugs in Intubated and Ventilated Intensive Care Unit Patients. aPatients could have more than 1 reason for exclusion; the most important reason was reported. bPatients in the on-demand group and routine group who had at least 1 protocol deviation were excluded from the per-protocol analysis.
Figure 2.
Figure 2.. Freedom From Invasive Ventilation, 90-Day Mortality, and ICU and Hospital Length of Stay in the Randomization Groups
ICU, intensive care unit.
See this image and copyright information in PMC

Comment in

References

    1. Icard BL, Rubio E. The role of mucoactive agents in the mechanically ventilated patient: a review of the literature. Expert Rev Respir Med. 2017;11(10):807-814. - PubMed
    1. Konrad F, Schreiber T, Brecht-Kraus D, et al. Mucociliary transport in ICU patients. Chest. 1994;105:237-241. - PubMed
    1. Dickson RP. The microbiome and critical illness. Lancet Respir Med. 2016;4(1):59-72. - PMC - PubMed
    1. Rubin BK. The pharmacologic approach to airway clearance: mucoactive agents. Respir Care. 2002;47(7):818-822. - PubMed
    1. Konrad F, Schoenberg MH, Wiedmann H, et al. The application of N-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients: a prospective, randomized, placebo-controlled, double-blind study. Anaesthesist. 1995;44(9):651-658. - PubMed

Associated data